IL-7R-α-γ binding compounds
US11965015B2 · kind B2 · utility
0Cited by
8References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2023 |
| Grant date | Apr 23, 2024 |
| Priority date | — |
| Expiry date | Jul 11, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
IL-7Rαγc binding compounds and pharmaceutical compositions comprising the IL-7Rαγc binding compounds are disclosed. IL-7Rαγc bonding compounds can act as IL-7R agonists and are useful in treating cancer, viral diseases, autoimmune diseases, and inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.